Literature DB >> 10731469

The hyperinsulinaemic-euglycaemic glucose clamp: reproducibility and metabolic effects of prolonged insulin infusion in healthy subjects.

M Soop1, J Nygren, K Brismar, A Thorell, O Ljungqvist.   

Abstract

To examine the reproducibility of the hyperinsulinaemic-euglycaemic clamp technique at mid-physiological hyperinsulinaemia, seven healthy subjects ¿age 50 (25, 59) years [median (range)], body mass index 23.1 (20.8, 25.5) kg.m(-2)¿ were investigated with three 2 h hyperinsulinaemic (60 micromol.l(-1))-euglycaemic (4.5 mmol.l(-1)) clamps performed 48 h and 14 days apart respectively. The third clamp was prolonged to 8 h in order to examine effects on glucose disposal during prolonged clamps. The glucose infusion rates (GIRs) during the three 2 h clamps were 7.41 (4.28, 10.96), 7.26 (5.38, 11. 02) and 6.63 (4.42, 10.3) mg.kg(-1).min(-1), with a median intra-individual coefficient of variation of 5.8 (2.6, 22) %. During the 8 h clamp a highly variable gradual increase in GIR was observed, reaching a plateau between 4 and 5 h at 32 (5, 101) % above the GIR between 1 and 2 h (P<0.05). This increase was correlated inversely with the GIR between 1 and 2 h (r=-0.82; P<0.05), and directly with age (r=0.86; P<0.05). Carbohydrate oxidation measured by indirect calorimetry was stable during the repeated 2 h clamps and the 8 h clamp. Endogenous glucose production measured by infusion of [6, 6-(2)H(2)]glucose was suppressed during the 8 h clamp. The 2 h hyperinsulinaemic-euglycaemic clamp is reproducible at a mid-physiological range of hyperinsulinaemia. If prolonged, it results in a delayed increase in non-oxidative glucose disposal, which is most pronounced in subjects with low insulin sensitivity. The findings underline the importance of selecting age-matched controls in studies of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731469     DOI: 10.1042/cs0980367

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  Multi-year reproducibility of hyperinsulinemic euglycemic clamp-derived insulin sensitivity in free-living adults: Association with incident prediabetes in the POP-ABC study.

Authors:  Deirdre James; Nkiru Umekwe; Chimaroke Edeoga; Ebenezer Nyenwe; Sam Dagogo-Jack
Journal:  Metabolism       Date:  2020-05-20       Impact factor: 8.694

2.  Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease.

Authors:  F Magkos; E Fabbrini; K Korenblat; A L Okunade; B W Patterson; S Klein
Journal:  Int J Obes (Lond)       Date:  2010-12-21       Impact factor: 5.095

3.  Acute free fatty acid elevation eliminates endurance training effect on insulin sensitivity.

Authors:  Lisa S Chow; Elizabeth R Seaquist; Lynn E Eberly; Mara T Mashek; Jill M Schimke; K Sreekumaran Nair; Doug G Mashek
Journal:  J Clin Endocrinol Metab       Date:  2012-05-25       Impact factor: 5.958

4.  Pharmacokinetic and pharmacodynamic bioequivalence between regular human insulin (rDNA origin) in 0.9% sodium chloride ready-to-use infusion 1 U/mL and 100 U/mL concentrate diluted to 1 U/mL in healthy males.

Authors:  Marcus Hompesch; Aleksandra Hawryluk; Moises Hernandez; Beena Uchil; Alyssa Wilmington; Lucas Peterson
Journal:  Diabetes Obes Metab       Date:  2021-09-08       Impact factor: 6.408

5.  Repeatability and reproducibility of the hyperinsulinemic-euglycemic clamp and the tracer dilution technique in a controlled inpatient setting.

Authors:  Duc Son N T Le; Thomas Brookshire; Jonathan Krakoff; Joy C Bunt
Journal:  Metabolism       Date:  2009-03       Impact factor: 8.694

6.  Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study.

Authors:  Yi Tao; Mingxue Zhu; Junliang Pu; Peilin Zhang; Lei Wan; Chengyong Tang
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

Review 7.  Measuring and estimating insulin resistance in clinical and research settings.

Authors:  Amalia Gastaldelli
Journal:  Obesity (Silver Spring)       Date:  2022-08       Impact factor: 9.298

8.  Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.

Authors:  Melody A de Laat; Kaylynn J Gruntmeir; Christopher C Pollitt; Catherine M McGowan; Martin N Sillence; Véronique A Lacombe
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-22       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.